跳至主要内容
临床试验/CTRI/2025/12/098372
CTRI/2025/12/098372尚未招募2/3 期

Comparison of standard and high dose mifepristone regimen for labour induction after foetal demise

PGIMER1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年12月15日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
PGIMER
入组人数
60
试验地点
1
主要终点
Induction delivery interval

研究概览

简要总结

This pilot randomized controlled trial aims to evaluate whether a high-dose mifepristone regimen is more effective than the standard dose for induction of labor in cases of intrauterine fetal demise. The study assesses the impact of increasing mifepristone dose on reducing the induction to delivery interval, lowering the total misoprostol requirement, and improving the rate of successful vaginal delivery. The trial also examines whether high-dose mifepristone can minimize misoprostol-related adverse effects, thereby enhancing the overall safety and effectiveness of the induction process.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
Female

入选标准

  • Singleton pregnancy Confirmed IUFD of 28 weeks or more Longitudinal lie.

排除标准

  • Patient in whom mifepristone is contraindicated Unknown scar Previous 2 or more LSCS Low lying placenta History of myomectomy Medical surgical disorders.

结局指标

主要结局

Induction delivery interval

时间窗: Baseline,48 hours,72 hours

次要结局

  • Number of successful vaginal delivery(48 hours)
  • Reduction in requirement & total dosage of misoprostol used(72 hours)

研究者

发起方
PGIMER
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Sanchita Jha

Post Graduate institute of medical education and research

研究点 (1)

Loading locations...

相似试验